Chest Wall Tuberculosis: Clinical Features and Treatment Outcomes / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 318-324, 2009.
Article
in English
| WPRIM
| ID: wpr-222131
ABSTRACT
BACKGROUND:
A diagnosis and treatment of chest wall tuberculosis (CWTB) is both difficult and controversial. The aim of this study was to collect information on the optimal treatment for CWTB.METHODS:
The clinical features, radiographic findings, and treatment outcomes of 26 patients, who underwent surgery and were diagnosed histopathologically, were retrospectively analyzed.RESULTS:
The most common presenting symptom was a palpable mass found in 24 patients (92.3%). In all patients, CT revealed a soft tissue mass that was accompanied by a central low density, with or without peripheral rim enhancement. The sensitivity and specificity of the bone scintigram for bone involvement were 87.5% and 100%, respectively. CWTB was diagnosed preoperatively by aspiration cytology and smear for acid-fast bacilli in five out of 11 patients. Twenty-three patients (88.5%) underwent a radical excision and three underwent incision/drainage or an incisional biopsy. The duration of antituberculous medication was 7.5+/-3.98 months with a follow-up period of 28.2+/-26.74 months. Among the 20 patients who completed their treatment, nine received chemotherapy for six months or less and 11 received chemotherapy for nine months or more. Two patients had a recurrence four and seven months after starting their medication.CONCLUSION:
A 6 month regimen may be appropriate for CWTB patients who have undergone a complete excision.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Recurrence
/
Thorax
/
Tuberculosis
/
Biopsy
/
Retrospective Studies
/
Follow-Up Studies
/
Thoracic Wall
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Tuberculosis and Respiratory Diseases
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS